Can Music Change How You Feel About Your Body?
Explore how music influences body image, self-esteem, and body positivity through playlist analysis and survey findings.
Mounjaro – also known by its ingredient name, tirzepatide – is a popular injectable weight loss treatment. Read on for your guide to what it does, how to get it and much you can expect to pay for Mounjaro online.
First prescribed for the treatment of type 2 diabetes, Mounjaro was approved by the FDA to treat weight loss in 2023. (1)
Mounjaro is a type of medication known as a GIP/GLP-1 receptor agonist and works by mimicking the action of the GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) hormones, which the body naturally releases after eating to trigger the production of insulin. This helps manage blood sugar levels and can make you feel full after eating and reduces your appetite. Clinical trials have shown it's possible to lose up to 20.9% of your body weight in 72 weeks with Mounjaro (tirzepatide). (2) Mounjaro is a weekly injection, self-administered using a pre-filled injection pen.
There are currently a number of GLP-1 weight loss treatments available, which contain different active ingredients; Ozempic and Wegovy use semaglutide – though Ozempic at a lower dose and used primarily for type-2 diabetes – Mounjaro uses tirzepatide and Saxenda uses liraglutide. As weight loss drugs, they all work in similar ways – the insulin released slows down stomach emptying and increases feelings of fullness to help you lose weight. The key difference with Mounjaro is that it’s a dual-acting medication, working on two different receptors: GIP and GLP-1. This dual action helps regulate your insulin levels and reduces your appetite while increasing how full you feel.
As well as the branded medications mentioned above, it’s also now possible for licensed compounding pharmacies to create their own weight loss injections using semaglutide. Which we can provide here at Levity. The benefits of choosing compounded semaglutide is that it’s significantly cheaper than the branded alternatives and can be enhanced with other ingredients like Vitamin B12 which may help combat nausea, a common side effect of weight loss medication.
When you complete your Levity online questionnaire, our healthcare professionals will recommend the right weight loss treatment for you depending on your medical history.
The short answer is yes. However, it’s not possible to get Mounjaro or any other injectable weight loss medication without a prescription. If you choose Levity as your weight loss partner, you will first fill in an online consultation form, which involves answering some questions about your medical history and weight loss goals. If you meet the eligibility criteria and our healthcare providers are happy that weight loss injections are the right treatment for you, they’ll then prescribe your medication and it will be delivered to your door each month.
Even though our service is provided entirely online, our US-based clinical team understands the importance of a holistic approach to weight management. So you’ll also have access to continued clinical support and health coaching – with advice on regular exercise and maintaining a healthy diet – throughout your weight loss journey.
At Levity, the monthly cost for Mounjaro is $1,299, which includes your consultation, prescription, medication, weekly self-injectable pen, clinical check-ins and access to our health coaches. The full list detailing the cost of medication for all our GLP-1 treatments starting from $225 per month can be found on our website.
Ready to lose weight and keep it off for good? Start with Levity today.
1. Farzam K, Patel P. Tirzepatide [Internet]. PubMed. Treasure Island (FL): StatPearls Publishing; 2022. Available from: https://www.ncbi.nlm.nih.gov/books/NBK585056
2. Jastreboff AM, Aronne LJ, Ahmad NN, Wharton S, Connery L, Alves B, et al. Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine [Internet]. 2022 Jun 4;387(3). Available from: https://www.nejm.org/doi/full/10.1056/NEJMoa2206038